Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | C135Y |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TP53 C135Y lies within the DNA-binding domain of the Tp53 protein (UniProt.org). C135Y confers a loss of function to the Tp53 protein as demonstrated by loss of binding to the Drosha complex, inability to induce downstream miRs, loss of transactivation activity in cell culture (PMID: 19626115, PMID: 8336941), increased colony formation compared to wild-type in the presence of an MDM2 antagonist in cell culture, and tumor growth in mouse models (PMID: 35165384). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon5 TP53 C135Y TP53 mutant TP53 inact mut TP53 C135Y |
Transcript | NM_000546.6 |
gDNA | chr17:g.7675208C>T |
cDNA | c.404G>A |
Protein | p.C135Y |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000546.5 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7675208C>T | c.404G>A | p.C135Y | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
TP53 C135Y | peritoneum cancer | sensitive | APR-246 + Cisplatin | Preclinical - Patient cell culture | Actionable | In a preclinical study, the combination of APR-246 and Platinol (cisplatin) resulted in strong synergism, thereby reducing cell viability in patient derived peritoneum cancer cells harboring TP53 C135Y in culture (PMID: 27179933). | 27179933 |